Lifecore Biomedical, Inc. (LFCR)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$5.13
+0.98%
Mkt Cap $261.51M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$6.50
Range $5.00 – $8.00
Implied Upside
+26.7%
Consensus $6.50 vs current $5.13